Here, we leverage such recognition models to track SARS-CoV-2 epitope-specificity in publicly available bulk TCR repertoires of COVID-19 patients (28) and in sorted CD4+ and CD8+ TCR repertoires of newly recruited COVID-19 patients. This evidence concerns the gene CD8A and COVID-19.